KPV is a tripeptide fragment of α-MSH with targeted anti-inflammatory and immunomodulatory properties. By selectively attenuating pro-inflammatory pathways such as NF-κB and TNF-α without compromising immune surveillance, KPV offers a novel approach to managing chronic inflammation, gastrointestinal dysregulation, and autoimmune conditions.